Where does Radiance Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Radiance Therapeutics, Inc. ranks #42,563 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Radiance Therapeutics, Inc. hold?

Radiance Therapeutics, Inc. holds 6 US utility patents granted between 2021 and 2025, spanning 3 technology areas.

What is Radiance Therapeutics, Inc.'s Innovation Score?

Radiance Therapeutics, Inc. has an Innovation Score of 23.7 out of 100 (13th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Radiance Therapeutics, Inc. focus on?

Radiance Therapeutics, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 2 patents, ranking #1,128 of 1,943 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Radiance Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Radiance Therapeutics, Inc..

What does claim depth mean for Radiance Therapeutics, Inc.'s patents?

Radiance Therapeutics, Inc.'s patents average 7.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Radiance Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Radiance Therapeutics, Inc.

USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Radiance ranks #42,563 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.

#42,563
of 49,997 US assignees by volume: 13th percentile
by Innovation Score (23.7/100): 7.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R42563 · US Corporation #42,563 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #42,563/49,997
PHOTO-FINISH Race Oncology
CPC-NARROW A61N · 3 areas
INNOV-THIN 23.7/100
CLAIMS-SPARSE 7.0 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Race Oncology Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Radiance’s 23.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (28%) Velocity 6.7 pts (28%) Breadth 6.1 pts (26%) Claim depth 4.2 pts (18%)

Qualcomm Incorporated · highest

85
Radiance Therapeutics · this assignee

24
3D Lighting… · lowest

7

What this shows Radiance's Innovation Score is 23.7/100 (13th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Radiance?

Each dot is one of Radiance’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Radiance’s own 7.0 claims/patent is at or below the 13.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Radiance vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Radiance's grants concentrate

Radiance Therapeutics, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 33.3% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). By volume, Radiance sits between RVT Group Limited and Rapiscan Laboratories, Inc..

Radiance's three-year grant acceleration

Radiance Therapeutics, Inc. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

RVT Group

6
Race Oncology

6
Rad Technology Me…

6
Radiadyne

6
Radical Plastics

6
Radius Garden L L…

6
Rakuten Marketing

6
Rapiscan Laborato…

6
Radiance Therapeu… ◀

6

What this shows Radiance holds 6 patents at rank #42,620, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Radiance

By rank, the assignees closest to #42,620 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Radiance's primary technology class.

Radiance's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 13th percentile higher than 13% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Radiance Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	33.3%
2023	2	33.3%
2025partial year	2	33.3%

Which technologies does Radiance Therapeutics, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Radiance Therapeutics, Inc.'s patent record in context - here's where to go next.

Radiance Therapeutics, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 33.3% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #42,563 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Radiance Therapeutics, Inc. against RVT Group Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 23.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.